Loading…

3303 Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patients with advanced melanoma (MEL) (CheckMate 067)

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2015-09, Vol.51, p.S664-S665
Main Authors: Larkin, J, Chiarion-Sileni, V, Gonzalez, R, Grob, J.J, Cowey, C.L, Lao, C.D, Wagstaff, J, Hogg, D, Hill, A, Carlino, M.S, Wolter, P, Lebbé, C, Schachter, J, Thomas, L, Hassel, J.C, Lorigan, P, Walker, D, Jiang, J, Hodi, F.S, Wolchok, J.D
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)31822-6